146 related articles for article (PubMed ID: 37752606)
1. Definitive irradiation as a first treatment strategy for primary and metastatic sites of newly diagnosed IVB cervical cancer that presented with synchronous oligometastases.
Li J; Wang Y; Huo L; Huang X; Shi L; Huang L; Chen K; Cao X
Radiat Oncol; 2023 Sep; 18(1):159. PubMed ID: 37752606
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and the role of primary debulking in operable stage IVB ovarian cancer with supraclavicular lymph node metastasis: a retrospective study in Chinese patients.
Quan C; Chen X; Wen H; Wu X; Li J
BMC Cancer; 2024 May; 24(1):565. PubMed ID: 38711015
[TBL] [Abstract][Full Text] [Related]
3. Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer.
Ning MS; Ahobila V; Jhingran A; Stecklein SR; Frumovitz M; Schmeler KM; Eifel PJ; Klopp AH
Gynecol Oncol; 2018 Jan; 148(1):132-138. PubMed ID: 29089122
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic characteristics and survival analysis in stage IVB cervical cancer with hematogenous metastasis.
Li H; Yang Y; Zhou H; Liu F; Li M; Chen L; Wu X; Cheng X
Transl Cancer Res; 2019 Aug; 8(4):1217-1223. PubMed ID: 35116863
[TBL] [Abstract][Full Text] [Related]
5. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in definitive radiotherapy of uterine cervical cancer.
Yalman D; Aras AB; Ozkök S; Duransoy A; Celik OK; Ozsaran Z; Haydaroğlu A
Eur J Gynaecol Oncol; 2003; 24(3-4):309-14. PubMed ID: 12807246
[TBL] [Abstract][Full Text] [Related]
7. Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.
Kubota H; Tsujino K; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Soejima T; Yamaguchi S; Sasaki R
Radiat Oncol; 2019 Dec; 14(1):236. PubMed ID: 31878944
[TBL] [Abstract][Full Text] [Related]
8. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes following conventional external beam radiotherapy boost in Japanese patients with cervical cancer who are ineligible for intracavitary brachytherapy.
Ito K; Shimizuguchi T; Karasawa K
Jpn J Clin Oncol; 2019 Mar; 49(3):270-275. PubMed ID: 30576504
[TBL] [Abstract][Full Text] [Related]
10. Outcome of Radiation Therapy for Stage IVB Uterine Cervical Cancer With Distant Lymph Nodes Metastases; Sequential Irradiation for Distant Lymph Nodes Metastases.
Mukai Y; Yokota NR; Sugiura M; Mizushima T; Taniuchi R; Imai Y; Hashimoto K; Tabuchi Y; Miyagi E; Hata M
In Vivo; 2021; 35(2):1169-1176. PubMed ID: 33622917
[TBL] [Abstract][Full Text] [Related]
11. Clinical Outcomes of Volumetric Modulated Arc Therapy Following Intracavitary/Interstitial Brachytherapy in Cervical Cancer: A Single Institution Retrospective Experience.
Lin Y; Ouyang Y; Chen K; Lu Z; Liu Y; Cao X
Front Oncol; 2019; 9():760. PubMed ID: 31475110
[No Abstract] [Full Text] [Related]
12. Curative chemoradiotherapy in patients with stage IVB cervical cancer presenting with paraortic and left supraclavicular lymph node metastases.
Kim JY; Kim JY; Kim JH; Yoon MS; Kim J; Kim YS
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):741-7. PubMed ID: 22898382
[TBL] [Abstract][Full Text] [Related]
13. Intensity Modulated Radiation Therapy and Image-Guided Adapted Brachytherapy for Cervix Cancer.
Lin AJ; Kidd E; Dehdashti F; Siegel BA; Mutic S; Thaker PH; Massad LS; Powell MA; Mutch DG; Markovina S; Schwarz J; Grigsby PW
Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1088-1097. PubMed ID: 30445171
[TBL] [Abstract][Full Text] [Related]
14. [Outcomes and prognostic factors of advanced squamous cervical cancer after concurrent chemoradiotherapy].
Binbin T; Lingying W; Manni H; Jusheng A; Ning L
Zhonghua Fu Chan Ke Za Zhi; 2014 May; 49(5):348-54. PubMed ID: 25030731
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
16. Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors.
Chyle V; Zagars GK; Wheeler JA; Wharton JT; Delclos L
Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):891-905. PubMed ID: 8751398
[TBL] [Abstract][Full Text] [Related]
17. The Efficacy of Volumetric Modulated Arc Therapy Combined With Chemotherapy, Brachytherapy, and Local Hyperthermia on Patients with Locally Advanced Cervical Cancer: A Retrospective Study.
Jiang P; Wei S; Bai Y; Qu A; Jiang W; Sun H; Wang J
Technol Cancer Res Treat; 2023; 22():15330338231185013. PubMed ID: 37357685
[TBL] [Abstract][Full Text] [Related]
18. Analysis of recurrence of squamous cell carcinoma of the uterine cervix after definitive radiation therapy alone: patterns of recurrence, latent periods, and prognosis.
Sakurai H; Mitsuhashi N; Takahashi M; Akimoto T; Muramatsu H; Ishikawa H; Imai R; Yamakawa M; Hasegawa M; Niibe H
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1136-44. PubMed ID: 11483322
[TBL] [Abstract][Full Text] [Related]
19. Definitive vs palliative pelvic radiation for patients with newly diagnosed stage IVB cervical cancer treated with bevacizumab - An exploratory study.
Wiley RL; Bondre IL; Jalloul R; Klopp AH; Taylor JS; Ramondetta LM
Gynecol Oncol Rep; 2022 Apr; 40():100963. PubMed ID: 35345549
[TBL] [Abstract][Full Text] [Related]
20. Definitive pelvic radiation therapy improves survival in stage IVB neuroendocrine cervical carcinoma: A NeCTuR study.
Salvo G; Jhingran A; Ramalingam P; Legarreta AF; Bhosale P; Gonzales NR; Chisholm GB; Frumovitz M
Gynecol Oncol; 2022 Jun; 165(3):530-537. PubMed ID: 35396134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
